CRYSTAL WOOD: Open Payments
NPI 1891373288 · BAXLEY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,021 in 62 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $39 · 2025 $1,021
Food & beverage: $1,021
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $306 |
| Lundbeck LLC | 9 | $195 |
| Vanda Pharmaceuticals Inc. | 11 | $153 |
| Tris Pharma Inc | 11 | $146 |
| Otsuka America Pharmaceutical, Inc. | 5 | $114 |
| Neos Therapeutics, LP | 2 | $34 |
| Alkermes, Inc. | 1 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: REXULTI, CAPLYTA, FANAPT, Dyanavel XR, ARISTADA, Qelbree, TRINTELLIX, Adzenys XR-ODT.
Industry payments across GA — which companies pay providers there.
